Movement Alert｜XTALPI Rises 5.24% in Regular Trading, Chairman Plans to Purchase Up to HK$32 Million in Shares

Market Focus09-21 10:07

On September 21, XTALPI rose 5.24% in regular trading, trading at HK$8.445/share, with turnover of HK$733 million. The stock continued its upward momentum following a 16.32% surge in the prior session.

On the news front, XTALPI announced that Chairman, Executive Director and Co-founder Dr. Wen Shuhao plans to purchase the company's ordinary shares on the open market using personal funds before the end of October, with total consideration not exceeding HK$32 million. The company will not participate in or provide any financial assistance for this plan. The board stated the plan reflects Dr. Wen's confidence in the company's long-term development prospects and investment value.

The share purchase plan adds to a series of recent positive developments. XTALPI's wholly-owned subsidiary LCC Technologies recently signed a drug discovery collaboration agreement with Stanford University, combining Stanford's disease biology research with LCC's AI-driven small molecule drug discovery platform. The company has also been conducting share buybacks on the secondary market throughout September. Multiple favorable catalysts continue to support market sentiment toward the stock.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1190332774?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-21 10:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190332774","market":"hk","top_or_hot":-1,"title":"Movement Alert｜XTALPI Rises 5.24% in Regular Trading, Chairman Plans to Purchase Up to HK$32 Million in Shares","media":"Market Focus","content":"<p><p>On September 21, XTALPI rose 5.24% in regular trading, trading at HK$8.445/share, with turnover of HK$733 million. The stock continued its upward momentum following a 16.32% surge in the prior session.</p><p>On the news front, XTALPI announced that Chairman, Executive Director and Co-founder Dr. Wen Shuhao plans to purchase the company's ordinary shares on the open market using personal funds before the end of October, with total consideration not exceeding HK$32 million. The company will not participate in or provide any financial assistance for this plan. The board stated the plan reflects Dr. Wen's confidence in the company's long-term development prospects and investment value.</p><p>The share purchase plan adds to a series of recent positive developments. XTALPI's wholly-owned subsidiary LCC Technologies recently signed a drug discovery collaboration agreement with Stanford University, combining Stanford's disease biology research with LCC's AI-driven small molecule drug discovery platform. The company has also been conducting share buybacks on the secondary market throughout September. Multiple favorable catalysts continue to support market sentiment toward the stock.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜XTALPI Rises 5.24% in Regular Trading, Chairman Plans to Purchase Up to HK$32 Million in Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜XTALPI Rises 5.24% in Regular Trading, Chairman Plans to Purchase Up to HK$32 Million in Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-21 10:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 21, XTALPI rose 5.24% in regular trading, trading at HK$8.445/share, with turnover of HK$733 million. The stock continued its upward momentum following a 16.32% surge in the prior session.</p><p>On the news front, XTALPI announced that Chairman, Executive Director and Co-founder Dr. Wen Shuhao plans to purchase the company's ordinary shares on the open market using personal funds before the end of October, with total consideration not exceeding HK$32 million. The company will not participate in or provide any financial assistance for this plan. The board stated the plan reflects Dr. Wen's confidence in the company's long-term development prospects and investment value.</p><p>The share purchase plan adds to a series of recent positive developments. XTALPI's wholly-owned subsidiary LCC Technologies recently signed a drug discovery collaboration agreement with Stanford University, combining Stanford's disease biology research with LCC's AI-driven small molecule drug discovery platform. The company has also been conducting share buybacks on the secondary market throughout September. Multiple favorable catalysts continue to support market sentiment toward the stock.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02228","symbol_name":"晶泰控股","start_time":0,"source_url":"","article_id":"1190332774","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190332774","pubTimestamp":1789956435,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 21, XTALPI rose 5.24% in regular trading, trading at HK$8.445/share, with turnover of HK$733 million. The stock continued its upward momentum following a 16.32% surge in the prior...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02228":"晶泰控股"},"translate_title":"变动警报|XTALPI常规交易涨5.24% 主席拟购入最多3200万港元股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02228":1},"content_text":"On September 21, XTALPI rose 5.24% in regular trading, trading at HK$8.445/share, with turnover of HK$733 million. The stock continued its upward momentum following a 16.32% surge in the prior session.On the news front, XTALPI announced that Chairman, Executive Director and Co-founder Dr. Wen Shuhao plans to purchase the company's ordinary shares on the open market using personal funds before the end of October, with total consideration not exceeding HK$32 million. The company will not participate in or provide any financial assistance for this plan. The board stated the plan reflects Dr. Wen's confidence in the company's long-term development prospects and investment value.The share purchase plan adds to a series of recent positive developments. XTALPI's wholly-owned subsidiary LCC Technologies recently signed a drug discovery collaboration agreement with Stanford University, combining Stanford's disease biology research with LCC's AI-driven small molecule drug discovery platform. The company has also been conducting share buybacks on the secondary market throughout September. Multiple favorable catalysts continue to support market sentiment toward the stock.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1190332774","isCrawlerRequest":true}